David Williams, the outspoken investment banker and chairman of PolyNovo, says he makes no apologies for an aggressive management style that led to the abrupt exit of the burns treatment biotech ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In one of those mildly devastating hits I didn’t see coming, the CEO and Chairman of Polynovo (ASX: PNV) had a falling out recently. Unfortunately for me, the company did not acknowledge the problem ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Development of innovative medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb.

As of 12:16:37 pm AEDT. Market open.

Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the ...